Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice

[1]  R. Numan.  The Behavioral Neuroscience of the Septal Region , 2012, Springer New York.

[2]  G. Higgins,et al.  Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task , 2000, Behavioural Brain Research.

[3]  Carmen Martin-Ruiz,et al.  Nicotinic receptors in human brain: topography and pathology , 2000, Journal of Chemical Neuroanatomy.

[4]  T. Maviel,et al.  A 5-arm maze enables parallel measures of sustained visuo-spatial attention and spatial working memory in mice , 2000, Behavioural Brain Research.

[5]  M. Sarter,et al.  Sustained Visual Attention Performance-Associated Prefrontal Neuronal Activity: Evidence for Cholinergic Modulation , 2000, The Journal of Neuroscience.

[6]  M. Sarter,et al.  Increases in cortical acetylcholine release during sustained attention performance in rats. , 2000, Brain research. Cognitive brain research.

[7]  J. Rawlins,et al.  Effects of scopolamine on a novel choice serial reaction time task , 2000, The European journal of neuroscience.

[8]  M. Picciotto,et al.  Nicotinic Receptors in the Brain: Links between Molecular Biology and Behavior , 2000, Neuropsychopharmacology.

[9]  Agneta Nordberg,et al.  Neuronal nicotinic receptors in the human brain , 2000, Progress in Neurobiology.

[10]  D. Sanger,et al.  Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies , 2000, Psychopharmacology.

[11]  C. Gotti,et al.  Neuronal nicotinic receptors, important new players in brain function. , 2000, European journal of pharmacology.

[12]  E D Levin,et al.  Development of nicotinic drug therapy for cognitive disorders. , 2000, European journal of pharmacology.

[13]  B. Hahn,et al.  Nicotine in an animal model of attention. , 2000, European journal of pharmacology.

[14]  I. Stolerman,et al.  The role of nicotinic and muscarinic acetylcholine receptors in attention , 2000, Psychopharmacology.

[15]  Sohee Park,et al.  Nicotine Impairs Spatial Working Memory while Leaving Spatial Attention Intact , 2000, Neuropsychopharmacology.

[16]  J. Yakel,et al.  Nicotinic receptors in the brain: correlating physiology with function , 1999, Trends in Neurosciences.

[17]  M. Sarter,et al.  Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents , 1999, Neuroscience.

[18]  E. Vizi,et al.  Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system , 1999, Brain Research Reviews.

[19]  L. Wilkinson,et al.  Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype , 1999, The European journal of neuroscience.

[20]  P. Luiten,et al.  Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory , 1999, Progress in Neurobiology.

[21]  A. Chiba,et al.  Cognitive functions of the basal forebrain , 1999, Current Opinion in Neurobiology.

[22]  J. Hodges,et al.  Attention and executive deficits in Alzheimer's disease. A critical review. , 1999, Brain : a journal of neurology.

[23]  Ezio Tirelli,et al.  Selective effects of nicotine on attentional processes , 1999, Psychopharmacology.

[24]  E. Levin,et al.  Transdermal nicotine effects on attention , 1998, Psychopharmacology.

[25]  T. Maviel,et al.  28 Do central nicotinic and muscarinic cholinergic receptors play differential roles in attentional and episodic memory mechanisms? A study using a new 5-arm maze protocol , 1998, Journal of Physiology-Paris.

[26]  E. Levin,et al.  Nicotinic acetylcholine involvement in cognitive function in animals , 1998, Psychopharmacology.

[27]  Ian P. Stolerman,et al.  Nicotine enhances sustained attention in the rat under specific task conditions , 1998, Psychopharmacology.

[28]  Trey Sunderland,et al.  Combined Nicotinic and Muscarinic Blockade in Elderly Normal Volunteers: Cognitive, Behavioral, and Physiologic Responses , 1998, Neuropsychopharmacology.

[29]  A. Chiba,et al.  A re-examination of the role of basal forebrain cholinergic neurons in spatial working memory , 1998, Neuropharmacology.

[30]  R. Ridley,et al.  The Role of the Central Cholinergic Projections in Cognition: Implications of the Effects of Scopolamine on Discrimination Learning by Monkeys , 1998, Brain Research Bulletin.

[31]  P. Bushnell,et al.  Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention , 1997, Psychopharmacology.

[32]  M. Sarter,et al.  Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. , 1997, Brain research. Cognitive brain research.

[33]  E. Levin,et al.  Nicotinic System Involvement in Alzheimer’s and Parkinson’s Diseases , 1997, Drugs & aging.

[34]  G. Baylis,et al.  The Role of Attention in a Spatial Memory Task in Alzheimer Disease Patients , 1997, Alzheimer Disease and Associated Disorders.

[35]  E D Levin,et al.  Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze. , 1997, Behavioural pharmacology.

[36]  W. J. Jackson,et al.  Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418 , 1997, Psychopharmacology.

[37]  W. J. Jackson,et al.  Cognitive effects of nicotinic cholinergic receptor agonists in nonhuman primates , 1996 .

[38]  M. Sarter,et al.  Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. , 1996, Behavioral neuroscience.

[39]  M. Hasselmo.  Neuromodulation and cortical function: modeling the physiological basis of behavior , 1995, Behavioural Brain Research.

[40]  T. Durkin.  Spatial working memory over long retention intervals: Dependence on sustained cholinergic activation in the septohippocampal or nucleus basalis magnocellularis-cortical pathways? , 1994, Neuroscience.

[41]  B. Everitt,et al.  AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  ML Voytko,et al.  Basal forebrain lesions in monkeys disrupt attention but not learning and memory [published erratum appears in J Neurosci 1995 Mar;15(3): following table of contents] , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  J. Muir,et al.  Excitotoxic lesions of basal forebrain cholinergic neurons: Effects on learning, memory and attention , 1993, Behavioural Brain Research.

[44]  F. Bymaster,et al.  Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[45]  T. Durkin,et al.  Time gradient for post-test vulnerability to scopolamine-induced amnesia following the initial acquisition session of a spatial reference memory task in mice. , 1993, Behavioral and neural biology.

[46]  P. Boer,et al.  Raised glucose levels enhance scopolamine-induced acetylcholine overflow from the hippocampus: an in vivo microdialysis study in the rat , 1992, Behavioural Brain Research.

[47]  S. Gauthier,et al.  Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's Diseases , 1992, Journal of neurochemistry.

[48]  D. Mash,et al.  Loss of high‐affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: Implications for the failure of cholinergic replacement therapies , 1991, Annals of neurology.

[49]  M. Sarter.  Retrieval of well-learned propositional rules: Insensitive to changes in activity of individual neurotransmitter systems? , 1990, Psychobiology.

[50]  B. Sahakian,et al.  The Effects of Nicotine on Attention, Information Processing, and Short-Term Memory in Patients with Dementia of the Alzheimer Type , 1989, British Journal of Psychiatry.

[51]  L. Butcher,et al.  Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze. , 1989, Behavioral and neural biology.

[52]  S. R. Max.  Animal models of dementia: A synaptic neurochemical perspective Neurology and neurobiology, vol. 33. Edited by Joseph T. Coyle. ISBN 08-451-273-49, Alan R. Liss, New York, 1987. , 1988, Neurochemistry International.

[53]  A. Nagaoka,et al.  Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats , 1987, Brain Research.

[54]  D. Collerton,et al.  Cholinergic function and intellectual decline in Alzheimer's disease , 1986, Neuroscience.

[55]  J. Flood,et al.  Scopolamine effects on memory retention in mice: a model of dementia? , 1986, Behavioral and neural biology.

[56]  N. Butters,et al.  Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia. , 1986, Behavioral and neural biology.

[57]  W. Beatty,et al.  Scopolamine degrades spatial working memory but spares spatial reference memory: Dissimilarity of anticholinergic effect and restriction of distal visual cues , 1985, Pharmacology Biochemistry and Behavior.

[58]  T. Robbins,et al.  Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal , 1983, Behavioural Brain Research.

[59]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[60]  M. Cheal.  Scopolamine disrupts maintenance of attention rather than memory processes. , 1981, Behavioral and neural biology.

[61]  G. Handelmann,et al.  Hippocampus, space, and memory , 1979 .

[62]  E K Perry,et al.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.

[63]  K. Wesnes,et al.  The separate and combined effects of scopolamine and nicotine on human information processing , 2004, Psychopharmacology.

[64]  S. Dunnett.  Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats , 2004, Psychopharmacology.

[65]  K. Davis,et al.  Cholinergic modulation of memory in rats , 2004, Psychopharmacology.

[66]  T. Durkin,et al.  Transsynaptic Mechanisms Controlling Cholinergic Neuronal Activation in the Septohippocampal and nBM-Cortical Pathways: Differential Roles in Memory and Attentional Processes? , 2000 .

[67]  T. Robbins,et al.  Central cholinergic systems and cognition. , 1997, Annual review of psychology.

[68]  S. Arneric,et al.  The pharmacology of (-)-nicotine and novel cholinergic channel modulators. , 1997, Advances in pharmacology.

[69]  G. Lynch,et al.  Memory: Organization and locus of change , 1994 .

[70]  L. Butcher,et al.  Characterization of the cognitive effects of combined muscarinic and nicotinic blockade. , 1990, Behavioral and neural biology.

[71]  R. Morris,et al.  The Cholinergic Hypothesis of Memory: A Review of Animal Experiments , 1988 .

[72]  S. Iversen,et al.  Handbook of Psychopharmacology , 1988, Springer US.

[73]  W. J. Jackson,et al.  Nicotine enhances delayed matching-to-sample performance by primates. , 1988, Life sciences.

[74]  W. Beatty,et al.  Scopolamine impairs encoding and retrieval of spatial working memory in rats , 1986 .

[75]  K. Wesnes,et al.  Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task. , 1983, Neuropsychobiology.